GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » EV-to-EBITDA

Fujian Cosunter Pharmaceutical Co (SZSE:300436) EV-to-EBITDA : -15.62 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fujian Cosunter Pharmaceutical Co's enterprise value is ¥3,055.5 Mil. Fujian Cosunter Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-195.7 Mil. Therefore, Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA for today is -15.62.

The historical rank and industry rank for Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300436' s EV-to-EBITDA Range Over the Past 10 Years
Min: -550.7   Med: 93.31   Max: 1436.54
Current: -15.56

During the past 13 years, the highest EV-to-EBITDA of Fujian Cosunter Pharmaceutical Co was 1436.54. The lowest was -550.70. And the median was 93.31.

SZSE:300436's EV-to-EBITDA is ranked worse than
100% of 714 companies
in the Drug Manufacturers industry
Industry Median: 14.535 vs SZSE:300436: -15.56

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Fujian Cosunter Pharmaceutical Co's stock price is ¥17.28. Fujian Cosunter Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1.883. Therefore, Fujian Cosunter Pharmaceutical Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Fujian Cosunter Pharmaceutical Co EV-to-EBITDA Historical Data

The historical data trend for Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Cosunter Pharmaceutical Co EV-to-EBITDA Chart

Fujian Cosunter Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.18 89.39 481.76 -67.24 -23.01

Fujian Cosunter Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.00 -17.62 -19.66 -23.01 -17.09

Competitive Comparison of Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA falls into.



Fujian Cosunter Pharmaceutical Co EV-to-EBITDA Calculation

Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3055.521/-195.675
=-15.62

Fujian Cosunter Pharmaceutical Co's current Enterprise Value is ¥3,055.5 Mil.
Fujian Cosunter Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-195.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fujian Cosunter Pharmaceutical Co  (SZSE:300436) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Fujian Cosunter Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.28/-1.883
=At Loss

Fujian Cosunter Pharmaceutical Co's share price for today is ¥17.28.
Fujian Cosunter Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.883.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Fujian Cosunter Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Fujian Cosunter Pharmaceutical Co (SZSE:300436) Business Description

Traded in Other Exchanges
N/A
Address
Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.

Fujian Cosunter Pharmaceutical Co (SZSE:300436) Headlines

No Headlines